Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification

Free
Log In

Overview

The June BC TALKS will feature five expert physicians: Prof. Michael Gnant (Austria), Prof. Marc Thill (Germany), Prof. Maria-João Cardoso (Portugal) and Prof. Giancarlo Pruneri (Italy).
This will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A


This Activity for

  • Resident / Fellow
  • Physician

What I will learn?

• Share data on the latest data for abemaciclib for patients with HR+ HER2-breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice. It will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A


About Organizer

  • Virtual Medical Academy

Additional items to the activity

Optional Details Type Fee
Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification Certificate Certificate Free
VAT 15% Included